News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SIRENADE Pharmaceuticals AG Appoints Lynn Butler As New CEO


10/19/2005 5:11:23 PM

Sirenade Pharmaceuticals AG, a biotech start-up focused on therapeutics for neurodegenerative disease and pain, has appointed Lynn Butler as its new chief executive.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES